FOXO1 and metabolic dysfunction-associated steatohepatitis: We recapitulated this finding by real-time qRT-PCR assay, revealing that hepatic mRNA expression of FOXO1, but not FOXO3 and FOXO4, was significantly upregulated in patients with NASH (Figure 9G).